[Home ] [Archive]    
:: Main :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
Indexing Sources::
For Authors::
Publication ethics::
Registration::
Contact us::
Site Facilities::
::
Creative Commons License
AWT IMAGE

This Journal under a

Creative Commons Attribution-NonCommercial 4.0 International License.

..
Open Access Policy

AWT IMAGE

..
cope

AWT IMAGE

..
Registered in

AWT IMAGE

AWT IMAGE

..
:: Oct-Dec ::
Back to the articles list Back to browse issues page
Co-supplementation of Flaxseed and Hesperidin Improves Atherogenic Dyslipidemia in People with Excess Weight: A Randomized Controlled Clinical Trial
Samira Rabiei , Azita Hekmatdoost , Vahideh Behrouz , Zahra Yari *
Department of Nutrition Research, National Nutrition and Food Technology Research Institute and Faculty of Nutrition Sciences and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran , zahrayari_nut@yahoo.com
Abstract:   (14 Views)
Background and Objectives: The increase in the risk of cardiovascular diseases, one of the leading causes of death in the world, due to obesity is significant. This study was carried out suggesting palliative effects of the combination of brown flaxseed and hesperidin on atherogenic dyslipidemia in obese people.
Materials and Methods: In this randomized controlled study, 44 obese adults were randomly assigned to lifestyle modification (control group) or receiving combined brown flaxseed (30 g) and hesperidin (2 × 500 mg capsules) (intervention group) for 12 w. Atherogenic indices, anthropometric parameters and dietary intakes were recorded. The trial was registered in clinicaltrial.gov. with reg. no. NCT03737422.
Results: After 12 w of intervention, body mass index decreased significantly in groups; however, decrease of body mass index in intervention group was significantly higher than that in control group (p = 0.034). Comparing changes of atherogenic indices between the two groups indicated a significant difference in triglyceride glucose index, atherogenic index of plasma and cholesterol index between the two groups. After adjusting results for condetecteders, including baseline value of the outcome and mean changes in body mass index, waist circumference and energy intake, differences became significant for Castelli risk index-II and lipoprotein combine index.
Conclusions: The current results have shown that intake of a combination of flaxseed and hesperidin with lifestyle modification effectively improves atherogenic dyslipidemia.
Keywords: Atherogenic dyslipidemia, Flaxseed, Hesperidin, Lifestyle modification, Obesity
Full-Text [PDF 720 kb]   (8 Downloads)    
Article type: Research | Subject: Nutrition
Received: 2024/09/8 | Accepted: 2024/09/10
  • Twelve weeks of supplementation with 30 g of flaxseed and 1 g of hesperidin could significantly improve the atherogenic lipid profile.
  • The combination of flaxseed and hesperidin caused significant weight loss in obese people.
  • The combination of flaxseed and hesperidin significantly improves atherogenic indicators.
  • Flaxseed and hesperidin co-supplementation with lifestyle modification can improve atherogenic dyslipidemia.

Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML     Print



Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Back to the articles list Back to browse issues page
Nutrition and Food Sciences Research
Persian site map - English site map - Created in 0.05 seconds with 45 queries by YEKTAWEB 4660